Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

NCT02666664 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2230

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Atherosclerotic Cardiovascular Diseases

Interventions

DRUG: ETC-1002
DRUG: Placebo

Sponsor

Esperion Therapeutics, Inc.